✦ LIBER ✦

Assessing the combination of FOLFOX or FOLFIRI with bevacizumab, cetuximab, or both in metastatic colorectal cancer

✍ Scribed by Alan P. Venook; Charles D. Blanke; Richard M. Goldberg; Denise K. Reinke; Susan Sutherland; John R. Taylor; Pamela McAllister; Richard L. Schilsky

Book ID: 118628475
Publisher: Frontline Medical Communications, Inc.
Year: 2006
Tongue: English
Weight: 167 KB
Volume: 3
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(11)70756-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab plus FOLFIRI or FOLFOX in ch

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

✍ Astrid Lièvre; Emmanuelle Samalin; Emmanuel Mitry; Eric Assenat; Christine Boyer 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 588 KB

Hepatic Yttrium-90 Radioembolotherapy in

Hepatic Yttrium-90 Radioembolotherapy in Metastatic Colorectal Cancer Treated with Cetuximab or Bevacizumab

✍ Murthy, Ravi; Eng, Cathy; Krishnan, Sunil; Madoff, David C.; Habbu, Amit; Canet, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Treatment Patterns and Clinical Outcomes

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX-Bevacizumab or FOLFIRI-Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study

✍ Bendell, J. C.; Bekaii-Saab, T. S.; Cohn, A. L.; Hurwitz, H. I.; Kozloff, M.; Te 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 495 KB

Axitinib or Bevacizumab Plus FOLFIRI or

Axitinib or Bevacizumab Plus FOLFIRI or Modified FOLFOX-6 After Failure of First-Line Therapy for Metastatic Colorectal Cancer: A Randomized Phase II Study

✍ Bendell, Johanna C.; Tournigand, Christophe; Swieboda-Sadlej, Anna; Barone, Carl 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 292 KB

Bevacizumab plus FOLFIRI or FOLFOX as th

Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis

✍ Byung Woog Kang; Tae Won Kim; Jae-Lyun Lee; Min-Hee Ryu; Heung Moon Chang; Chang 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 188 KB

Survival of patients with initially unre

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)

✍ Folprecht, G.; Gruenberger, T.; Bechstein, W.; Raab, H.- R.; Weitz, J.; Lordick, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 278 KB